Journal of Biological Engineering, 2020 · DOI: https://doi.org/10.1186/s13036-020-00244-3 · Published: July 27, 2020
Spinal cord injuries (SCIs) can lead to nerve cell and tissue loss, along with complications like blood loss and inflammation. Fibrin hydrogels, derived from the extracellular matrix, are gaining attention for SCI repair due to their biocompatibility and ability to carry cells and growth factors. This review examines the advantages and disadvantages of fibrin hydrogels from various sources, along with modifications for guiding tissue growth during polymerization. It also assesses their use as carriers for stem cells, cytokines, and drugs to promote nerve repair and regeneration. The focus is on improving cell function before and after delivering cells, cytokines, and drugs, mirroring recent developments and challenges in nerve repair therapy using fibrin hydrogels.
Fibrin hydrogels can serve as a vehicle for delivering therapies, such as stem cells and drugs, directly to the injury site, potentially improving recovery outcomes.
Modifying fibrin hydrogels to provide topographical guidance can promote the alignment and elongation of regenerating axons, leading to better nerve regeneration.
Using autologous fibrin hydrogels derived from a patient's own plasma can reduce the risk of viral transmission and immune rejection.